Wang, M., He, X., Crawford, K., Ko, Y., Dickert, N. W., Patel, S. A., Pandey, A., DeFilippis, E. M., Breathett, K., Cogswell, R., Yancy, C. W., Fonarow, G. C., & Morris, A. A. (2025). Racial and Ethnic Disparities in Referral to Outpatient Heart Failure Management at Hospital Discharge: A Get With The Guidelines Analysis. Journal of the American Heart Association. https://doi.org/10.1161/jaha.124.036900

Davis, B. J., Kim, M., Burton, Y., Elman, M., Hodovan, J., Shah, A. M., Maurer, M. S., Solomon, S. D., & Masri, A. (2025). Myocardial contraction fraction predicts outcomes in patients enrolled in the TOPCAT trial. International Journal of Cardiology, 424, 133038. https://doi.org/10.1016/j.ijcard.2025.133038

Molinsky, R. L., Shah, A., Yuzefpolskaya, M., Yu, B., Misialek, J. R., Bohn, B., Vock, D., MacLehose, R., Borlaug, B. A., Colombo, P. C., Ndumele, C. E., Ishigami, J., Matsushita, K., Lutsey, P. L., & Demmer, R. T. (2025). Infection‐Related Hospitalization and Incident Heart Failure: The Atherosclerosis Risk in Communities Study. Journal of the American Heart Association. https://doi.org/10.1161/jaha.123.033877

Fontana, M., Maurer, M. S., Gillmore, J. D., Bender, S., Jay, P. Y., & Solomon, S. D. (2025). Worsening of Heart Failure in Outpatients With Transthyretin Amyloidosis and Cardiomyopathy in the APOLLO-B Trial. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2024.10.097

Ishiguchi, H., Chen, Y., Huang, B., Gue, Y., Correa, E., Homma, S., Thompson, J. L. P., Qian, M., Lip, G. Y. H., & Abdul‐Rahim, A. H. (2024). Machine learning for stroke in heart failure with reduced ejection fraction but without atrial fibrillation: A post‐hoc analysis of the WARCEF trial. European Journal of Clinical Investigation. Portico. https://doi.org/10.1111/eci.14360

Fontana, M., Maurer, M. S., Gillmore, J. D., Bender, S., Aldinc, E., Eraly, S. A., Jay, P. Y., & Solomon, S. D. (2024). Outpatient Worsening Heart Failure in Patients with Transthyretin Amyloidosis with Cardiomyopathy in the HELIOS-B Trial. Journal of the American College of Cardiology. https://doi.org/10.1016/j.jacc.2024.11.015

Reddy, Y. N. V., Frantz, R. P., Hassoun, P. M., Hemnes, A. R., Horn, E., Leopold, J. A., Rischard, F., Rosenzweig, E. B., Hill, N. S., Erzurum, S. C., Beck, G. J., Finet, J. E., Jellis, C. L., Mathai, S. C., Tang, W. H. W., & Borlaug, B. A. (2024). Clinical Implications of Pretest Probability of HFpEF on Outcomes in Precapillary Pulmonary Hypertension. Journal of the American College of Cardiology, 84(22), 2196–2210. https://doi.org/10.1016/j.jacc.2024.08.061

Xu, W., & Richmond, M. (2024). Advances in understanding and managing pediatric heart failure and transplant. Current Opinion in Pediatrics, 36(5), 489–495. https://doi.org/10.1097/mop.0000000000001393

Shaddy, R., Burch, M., Kantor, P. F., Solar-Yohay, S., Garito, T., Zhang, S., Kocun, M., Mao, C., Cilliers, A., Wang, X., Canter, C., Rossano, J., Wallis, G., Menteer, J., Daou, L., Kusa, J., Tokel, K., Dilber, D., Xu, Z., … Zuhlke, L. (2024). Sacubitril/Valsartan in Pediatric Heart Failure (PANORAMA-HF): A Randomized, Multicenter, Double-Blind Trial. Circulation, 150(22), 1756–1766. https://doi.org/10.1161/circulationaha.123.066605

Miotto, M. C., Reiken, S., Wronska, A., Yuan, Q., Dridi, H., Liu, Y., Weninger, G., Tchagou, C., & Marks, A. R. (2024). Structural basis for ryanodine receptor type 2 leak in heart failure and arrhythmogenic disorders. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-51791-y

Litwin, S. E., Komtebedde, J., Borlaug, B. A., Kaye, D. M., Hasenfuβ, G., Kawash, R., Hoendermis, E., Hummel, S. L., Cikes, M., Gustafsson, F., Chung, E. S., Mohan, R. C., Sverdlov, A. L., Swarup, V., Winkler, S., Hayward, C. S., Bergmann, M. W., Bugger, H., McKenzie, S., … Shah, S. J. (2024). Long term safety and outcomes after atrial shunting for heart failure with preserved or mildly reduced ejection fraction: 5-year and 3-year follow-up in the REDUCE LAP-HF I and II trials. American Heart Journal, 278, 106–116. https://doi.org/10.1016/j.ahj.2024.08.014

Grady, K. L., Dew, M. A., Pagani, F. D., Spertus, J. A., Hsich, E., Yuzefpolskaya, M., Lampert, B., Kirklin, J. K., Petty, M., Kao, A., Yancy, C., Hartupee, J., Pamboukian, S. V., Johnson, M., Murray, M., Wu, T., & Andrei, A.-C. (2024). A comparison of quality-adjusted life years in older adults after heart transplantation versus long-term mechanical support: Findings from the SUSTAIN-IT study. The Journal of Heart and Lung Transplantation, 43(9), 1422–1433. https://doi.org/10.1016/j.healun.2024.05.008

Yuzefpolskaya, M., Bohn, B., Ladanyi, A., Pinsino, A., Braghieri, L., Carey, M. R., Clerkin, K., Sayer, G. T., Latif, F., Koji, T., Uriel, N., Nandakumar, R., Uhlemann, A.-C., Colombo, P. C., & Demmer, R. T. (2024). Alterations in the sarcopenia index are associated with inflammation, gut, and oral microbiota among heart failure, left ventricular assist device, and heart transplant patients. The Journal of Heart and Lung Transplantation, 43(9), 1395–1408. https://doi.org/10.1016/j.healun.2024.04.069

Lahiri, S. K., Lu, J., Aguilar-Sanchez, Y., Li, H., Moreira, L. M., Hulsurkar, M. M., Mendoza, A., Turkieltaub Paredes, M. R., Navarro-Garcia, J. A., Munivez, E., Horist, B., Moore, O. M., Weninger, G., Brandenburg, S., Lenz, C., Lehnart, S. E., Sayeed, R., Krasopoulos, G., Srivastava, V., … Wehrens, X. H. T. (2024). Targeting calpain-2-mediated junctophilin-2 cleavage delays heart failure progression following myocardial infarction. Journal of Molecular and Cellular Cardiology, 194, 85–95. https://doi.org/10.1016/j.yjmcc.2024.06.011

Shih, H., Mondellini, G. M., Kurlansky, P. A., Sun, J., Ning, Y., Feldman, V. R., Tiburcio, M., Maguire, C. W., Ladanyi, A., Clerkin, K., Naka, Y., Sayer, G. T., Uriel, N., Colombo, P. C., Takeda, K., & Yuzefpolskaya, M. (2024). Unplanned hospital readmissions following HeartMate 3 implantation: Readmission rates, causes, and impact on survival. Artificial Organs, 48(9), 1049–1059. Portico. https://doi.org/10.1111/aor.14763

Mohamoud, A., Abdallah, N., Wardhere, A., Teeri, S., & Ismayl, M. (2024). Sepsis and septic shock outcomes and 90-day readmissions in heart failure with reduced ejection fraction: A national readmission database study. Current Problems in Cardiology, 49(9), 102696. https://doi.org/10.1016/j.cpcardiol.2024.102696

Hahn, R. T., Lindenfeld, J., Lim, S. D., Mack, M. J., & Burkhoff, D. (2024). Structural Cardiac Interventions in Patients With Heart Failure. Journal of the American College of Cardiology, 84(9), 832–847. https://doi.org/10.1016/j.jacc.2024.05.061

Lang, F. M., Lee, B. C., Lotan, D., Sabuncu, M. R., & Topkara, V. K. (2024). Role of Artificial Intelligence and Machine Learning to Create Predictors, Enhance Molecular Understanding, and Implement Purposeful Programs for Myocardial Recovery. Methodist DeBakey Cardiovascular Journal, 20(4), 76–87. https://doi.org/10.14797/mdcvj.1392

Martinez‐Morata, I., Domingo‐Relloso, A., Zhang, Y., Fretts, A. M., Pichler, G., Garcia Pinilla, J. M., Umans, J. G., Cole, S. A., Sun, Y., Shimbo, D., Navas‐Acien, A., & Devereux, R. B. (2024). Heart Failure Risk Prediction in a Population With a High Burden of Diabetes: Evidence From the Strong Heart Study. Journal of the American Heart Association, 13(17). https://doi.org/10.1161/jaha.123.033772

Ibeh, C., Marshall, R. S., & Willey, J. Z. (2024). Race-ethnicity, age, and heart failure in ischemic stroke. Journal of Stroke and Cerebrovascular Diseases, 33(8), 107809. https://doi.org/10.1016/j.jstrokecerebrovasdis.2024.107809

Lewis, M. J., Schlendorf, K. H., & Reardon, L. C. (2024). Integrating risks and benefits: pretransplant assessment and patient selection for heart transplantation in adult congenital heart disease. Current Opinion in Organ Transplantation, 29(5), 305–309. https://doi.org/10.1097/mot.0000000000001170

Kambalapalli, S., Baral, N., Paul, T. K., Upreti, P., Talaei, F., Ayad, S., Ibrahim, M., Aggarwal, V., Kumar, G., Alraies, C., & Mitchell, J. (2024). Thirty-day hospital readmission in females with acute heart failure and breast cancer: A retrospective cohort study from national readmission database. PLOS ONE, 19(7), e0301596. https://doi.org/10.1371/journal.pone.0301596

Hahn, R. T., Lindenfeld, J., Böhm, M., Edelmann, F., Lund, L. H., Lurz, P., Metra, M., Tedford, R. J., Butler, J., & Borlaug, B. A. (2024). Tricuspid Regurgitation in Patients With Heart Failure and Preserved Ejection Fraction. Journal of the American College of Cardiology, 84(2), 195–212. https://doi.org/10.1016/j.jacc.2024.04.047

Wong, J. Y. Y., Blechter, B., Liu, Z., Shi, J., & Roger, V. L. (2024). Genetic susceptibility to chronic diseases leads to heart failure among Europeans: the influence of leukocyte telomere length. Human Molecular Genetics, 33(14), 1262–1272. https://doi.org/10.1093/hmg/ddae063

Sun, J., Yao, J., Olén, O., Halfvarson, J., Bergman, D., Ebrahimi, F., Rosengren, A., Sundström, J., & Ludvigsson, J. F. (2024). Risk of heart failure in inflammatory bowel disease: a Swedish population-based study. European Heart Journal, 45(28), 2493–2504. https://doi.org/10.1093/eurheartj/ehae338

Simpson, M. T., Ning, Y., Kurlansky, P., Colombo, P. C., Yuzefpolskaya, M., Uriel, N., Naka, Y., & Takeda, K. (2022). Outcomes of treatment for deep left ventricular assist device infection. The Journal of Thoracic and Cardiovascular Surgery. https://doi.org/10.1016/j.jtcvs.2022.09.020

Taylor, C. N., Ibrahim, N. E., & Youmans, Q. R. (2024). The Quagmire of Prognostication in Heart Failure. JACC: Heart Failure, 12(5), 890–892. https://doi.org/10.1016/j.jchf.2024.02.026

Shetty, N. S., Pampana, A., Patel, N., Maurer, M. S., Goyal, P., Li, P., Arora, G., & Arora, P. (2024). Carpal Tunnel Syndrome and Transthyretin Amyloidosis in the All of Us Research Program. Mayo Clinic Proceedings, 99(7), 1101–1111. https://doi.org/10.1016/j.mayocp.2023.11.016

Hamo, C. E., Mukhopadhyay, A., Li, X., Zheng, Y., Kronish, I. M., Chunara, R., Dodson, J., Adhikari, S., & Blecker, S. (2024). Association between visit frequency, continuity of care, and pharmacy fill adherence in heart failure patients. American Heart Journal, 273, 53–60. https://doi.org/10.1016/j.ahj.2024.04.003

Buch, M. H., Bhatt, D. L., Charles-Schoeman, C., Giles, J. T., Mikuls, T., Koch, G. G., Ytterberg, S., Nagy, E., Jo, H., Kwok, K., Connell, C. A., Masri, K. R., & Yndestad, A. (2024). Risk of extended major adverse cardiovascular event endpoints with tofacitinib versus TNF inhibitors in patients with rheumatoid arthritis: a post hoc analysis of a phase 3b/4 randomised safety study. RMD Open, 10(2), e003912. https://doi.org/10.1136/rmdopen-2023-003912

Reading Turchioe, M., Volodarskiy, A., Guo, W., Taylor, B., Hobensack, M., Pathak, J., & Slotwiner, D. (2023). Characterizing atrial fibrillation symptom improvement following de novo catheter ablation. European Journal of Cardiovascular Nursing, 23(3), 241–250. https://doi.org/10.1093/eurjcn/zvad068

Adamo, M., Russo, G., Pagnesi, M., Pancaldi, E., Alessandrini, H., Andreas, M., Badano, L. P., Braun, D., Connelly, K. A., Denti, P., Estevez-Loureiro, R., Fam, N., Gavazzoni, M., Hahn, R. T., Harr, C., Hausleiter, J., Himbert, D., Kalbacher, D., Ho, E., … Taramasso, M. (2024). Prediction of Mortality and Heart Failure Hospitalization After Transcatheter Tricuspid Valve Interventions. JACC: Cardiovascular Interventions, 17(7), 859–870. https://doi.org/10.1016/j.jcin.2024.02.013

Goyal, P., Maurer, M. S., & Roh, J. (2024). Aging in Heart Failure. JACC: Heart Failure, 12(5), 795–809. https://doi.org/10.1016/j.jchf.2024.02.021

Ibeh, C., Tom, S. E., Marshall, R. S., Elkind, M. S. V., & Willey, J. Z. (2024). Racial-Ethnic disparities in stroke prevalence among patients with heart failure. Journal of Clinical Neuroscience, 123, 173–178. https://doi.org/10.1016/j.jocn.2024.03.035

Wu, W., Jin, Q., Östlund, C., Tanji, K., Shin, J.-Y., Han, J., Leu, C.-S., Kushner, J., & Worman, H. J. (2024). mTOR Inhibition Prolongs Survival and Has Beneficial Effects on Heart Function After Onset of Lamin A/C Gene Mutation Cardiomyopathy in Mice. Circulation: Heart Failure, 17(4). https://doi.org/10.1161/circheartfailure.123.011110

COLOMBO, P. C., CASTAGNA, F., ONAT, D., WONG, K. Y., HARXHI, A., HAYASHI, Y., FRIEDMAN, R. A., PINSINO, A., LADANYI, A., MEBAZAA, A., JELIC, S., ARRIGO, M., LEJEMTEL, T. H., PAPAPANOU, P., SABBAH, H. N., SCHMIDT, A. M., YUZEFPOLSKAYA, M., & DEMMER, R. T. (2024). Experimentally Induced Peripheral Venous Congestion Exacerbates Inflammation, Oxidative Stress, and Neurohormonal and Endothelial Cell Activation in Patients With Systolic Heart Failure. Journal of Cardiac Failure, 30(4), 580–591. https://doi.org/10.1016/j.cardfail.2023.07.016

Bansal, N., D’Souza, N., Wisotzkey, B. L., Albers, E., Shih, R., Exil, V., McQueen, M., Hillenburg, J. P., Azeka, E., Law, S., Peng, D. M., O’Connor, M., Gajarski, R., Vanderpluym, C., Lorts, A., Barnes, A., Sojka, M., Bano, M., Keating, M., … Nandi, D. (2023). Successful implementation of telehealth visits in the paediatric heart failure and heart transplant population. Cardiology in the Young, 34(3), 531–534. https://doi.org/10.1017/s1047951123001312

Adamson, P. B., Echols, M., DeFilippis, E. M., Morris, A. A., Bennett, M., Abraham, W. T., Lindenfeld, J., Teerlink, J. R., O’Connor, C. M., Connolly, A. T., Li, H., Fiuzat, M., Vaduganathan, M., Vardeny, O., Batchelor, W., & McCants, K. C. (2024). Clinical Trial Inclusion and Impact on Early Adoption of Medical Innovation in Diverse Populations. JACC: Heart Failure, 12(7), 1212–1222. https://doi.org/10.1016/j.jchf.2024.02.015

Meier, D., Grant, D., Frawley, C., Akodad, M., Landes, U., Kokhar, A. A., Dudek, D., George, I., Rinaldi, M. J., Kim, W.-K., Yakubov, S. J., Sorajja, P., Tarantini, G., Wood, D. A., Webb, J. G., Sellers, S. L., & Sathananthan, J. (2024). Redo-TAVI with the ACURATE neo2 and Prime XL for balloon-expandable transcatheter heart valve failure. EuroIntervention, 20(6), e376–e388. https://doi.org/10.4244/eij-d-23-00783

Ostrominski, J. W., DeFilippis, E. M., Bansal, K., Riello, R. J., Bozkurt, B., Heidenreich, P. A., & Vaduganathan, M. (2024). Contemporary American and European Guidelines for Heart Failure Management. JACC: Heart Failure, 12(5), 810–825. https://doi.org/10.1016/j.jchf.2024.02.020

Haug, M., Oja, M., Pajusalu, M., Mooses, K., Reisberg, S., Vilo, J., Giménez, A. F., Falconer, T., Danilović, A., Maljkovic, F., Dawoud, D., & Kolde, R. (2024). Markov modeling for cost-effectiveness using federated health data network. Journal of the American Medical Informatics Association, 31(5), 1093–1101. https://doi.org/10.1093/jamia/ocae044

Lu, D. Y., Kanduri, J., Yeo, I., Goyal, P., Krishnan, U., Horn, E. M., Karas, M. G., Sobol, I., Majure, D. T., Naka, Y., Minutello, R. M., Cheung, J. W., Uriel, N., & Kim, L. K. (2024). Impact of Advanced Therapy Centers on Characteristics and Outcomes of Heart Failure Admissions. Circulation: Heart Failure, 17(3). https://doi.org/10.1161/circheartfailure.123.011115

Muraru, D., Badano, L. P., Hahn, R. T., Lang, R. M., Delgado, V., Wunderlich, N. C., Donal, E., Taramasso, M., Duncan, A., Lurz, P., De Potter, T., Zamorano Gómez, J. L., Bax, J. J., von Bardeleben, R. S., Enriquez-Sarano, M., Maisano, F., Praz, F., & Sitges, M. (2024). Atrial secondary tricuspid regurgitation: pathophysiology, definition, diagnosis, and treatment. European Heart Journal, 45(11), 895–911. https://doi.org/10.1093/eurheartj/ehae088

Ruberg, F. L., & Maurer, M. S. (2024). Cardiac Amyloidosis Due to Transthyretin Protein. JAMA, 331(9), 778. https://doi.org/10.1001/jama.2024.0442

Makmal, N., Silbermintz, N., Faierstein, K., Raphael, R., Moeller, C., Canetti, M., Maor, E., Kuperstein, R., Hai, I., Butnaru, A., Oren, D., Barbash, I. M., Guetta, V., & Fefer, P. (2024). Transcatheter edge-to-edge mitral valve repair in patients with acute decompensated heart failure due to severe mitral regurgitation. Cardiology Journal, 31(1), 45–52. https://doi.org/10.5603/cj.a2023.0042

GOYAL, P., DIDOMENICO, R. J., PRESSLER, S. J., IBEH, C., WHITE-WILLIAMS, C., ALLEN, L. A., GORODESKI, E. Z., Albert, N., Fudim, M., Lekavich, C., Watson, K., Gulati, S., Kalogeropoulos, A., & Lewsey, S. (2024). Cognitive Impairment in Heart Failure: A Heart Failure Society of America Scientific Statement. Journal of Cardiac Failure, 30(3), 488–504. https://doi.org/10.1016/j.cardfail.2024.01.003

Mangal, S., Niño de Rivera, S., Reading Turchioe, M., Myers, A., Benda, N., Goyal, P., Dugdale, L., & Masterson Creber, R. (2023). Perceptions of patient-reported outcome data access and sharing among patients with heart failure: ethical implications for research. European Journal of Cardiovascular Nursing, 23(2), 145–151. https://doi.org/10.1093/eurjcn/zvad046

LEE, C., LIANG, L. W., HASEGAWA, K., MAURER, M. S., TOWER-RADER, A., FIFER, M. A., REILLY, M., & SHIMADA, Y. J. (2024). Signaling Pathways Associated With Prior Cardiovascular Events in Hypertrophic Cardiomyopathy. Journal of Cardiac Failure, 30(3), 462–472. https://doi.org/10.1016/j.cardfail.2023.07.010

Romiti, G. F., Nabrdalik, K., Corica, B., Bucci, T., Proietti, M., Qian, M., Chen, Y., Thompson, J. L. P., Homma, S., & Lip, G. Y. H. (2024). Diabetes mellitus in patients with heart failure and reduced ejection fraction: a post hoc analysis from the WARCEF trial. Internal and Emergency Medicine, 19(4), 931–939. https://doi.org/10.1007/s11739-024-03544-4

Fernandez Valledor, A., Rubinstein, G., Moeller, C. M., Lorenzatti, D., Rahman, S., Lee, C., Oren, D., Farrero, M., Sayer, G. T., & Uriel, N. (2024). “Durable left ventricular assist devices as a bridge to transplantation in The Old and The New World.” The Journal of Heart and Lung Transplantation, 43(6), 1010–1020. https://doi.org/10.1016/j.healun.2024.01.019